CStone Pharmaceuticals, a China-based biopharmaceutical company, has entered into an exclusive commercialisation agreeme...
Japan-based Nippon Shinyaku has entered into an option agreement with US-based Elixirgen Therapeutics, Inc. under which ...
Mubadala Bio has announced the signing of a licencing and supply agreement with Biosidus, a leading biotechnology compan...
Australian startup 4DMedical Limited, the global leader in advanced respiratory imaging, has announced that CT:VQ™...
Research institutions generate groundbreaking discoveries every year, yet only a small fraction successfully reach patie...
Despite causing millions of serious infections and hundreds of thousands of deaths each year, fungal diseases continue t...
Cincinnati's life sciences ecosystem is gaining momentum through a unique combination of scientific excellence, collabor...
Oklahoma City's life sciences ambitions are increasingly centred on advanced manufacturing, collaboration, and long-term...
During BIO 2026 in San Diego, BioSpectrum Asia spoke with Kurt Imhof, Senior Vice President, Policy & Public Affairs...
During the BIO International Convention 2026 (June 22–25) in San Diego, BioSpectrum Asia spoke with Arthur Jackson...
During the BIO International Convention 2026 (June 22–25) in San Diego, BioSpectrum Asia spoke with Lan Nguyen, Ch...
During the BIO International Convention 2026 (June 22–25) in San Diego, BioSpectrum Asia spoke with Ella Woger-Nie...
While most cardiovascular research has traditionally focused on the heart and large blood vessels, a growing body of evi...
As obesity treatment enters a new phase of innovation, the industry is increasingly looking beyond GLP-1 therapies to ad...
As the pharmaceutical industry advances towards increasingly complex, poorly soluble drug candidates, formulation has ...
US-based Natera, Inc., a global leader in cell-free DNA and precision medicine, has announced that Signatera has re...
China-based Abbisko Therapeutics has entered into a strategic research collaboration and licence agreement with US-based...
Few therapeutic areas have witnessed the level of progress achieved in HIV over the past three decades...
While antimicrobial resistance (AMR) is often overshadowed by high-profile therapeutic areas such as oncology, its growi...
Artificial intelligence has long promised to transform healthcare, yet widespread adoption has often been hindered by ch...
Alzheimer's disease research has entered a pivotal new phase following the arrival of the first disease-modifying therap...
Indian startup IHLD MedTech has announced a strategic investment from UltraGreen.ai, a global leader in fluorescence-gui...
US-based Thermo Fisher Scientific has expanded its LABScreen™ Single Antigen ExPlex Portfolio with ...
As cannabis use expands globally and regulatory frameworks continue to evolve, healthcare systems are increasingly confr...
Autoimmune and inflammatory diseases frequently affect the eye, yet ophthalmology has largely remained on the sidelines ...
